J. H. Bourhis

1.0k citations

35 papers · 507 indexed · h-index 12

Hematology top 5%
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 3
Hepatology
Genetics
Oncology
- Neutropenia and Cancer Infections 4
Immunology
- Immune Cell Function and Interaction 5
Molecular Biology
- Cancer therapeutics and mechanisms 4
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 4
Surgery
- Testicular diseases and treatments 3

Co-authors: J L Pico Pierre Fenaux Serge Koscielny T. Girinski Christian Denier Olivier Hartmann Sylvie Chevret J. Leclère
Cited by: Hematology Hepatology Genetics
Journals: Leukemia (2 papers)Haematologica (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: France United States Italy

In The Last Decade

J. H. Bourhis

34 papers receiving 493 citations

Peers

Countries citing papers authored by J. H. Bourhis

Since Specialization

Citations

This map shows the geographic impact of J. H. Bourhis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Bourhis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Bourhis more than expected).

Fields of papers citing papers by J. H. Bourhis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. Bourhis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Bourhis. The network helps show where J. H. Bourhis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. H. Bourhis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. H. Bourhis Line = papers co-authored together J. H. Bourhis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry Bone Marrow Transplantation ·Alicja Sadowska‐Klasa,Jan Maciej Zaucha,Myriam Labopin,J. H. Bourhis,Didier Blaise,Ibrahim Yakoub‐Agha,Urpu Salmenniemi,Jakob Passweg,Nathalie Fegueux,Thomas Schroeder,Sebastian Giebel,Éolia Brissot,Fabio Ciceri,Mohamad Mohty	2024	0
2	Enhanced Cytotoxic Activity of Ex Vivo-differentiated Human Natural Killer Cells in the Presence of HOXB4 Journal of Immunotherapy ·Arash Nanbakhsh,Cécile Pochon,Sophie Amsellem,Gianfranco Pittari,Jean-FranÃ§ois Moreau,J. H. Bourhis,Salem Chouaı̈b	2014	3
3	Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy Haematologica ·Téreza Coman,Emmanuel Bachy,Suzana Hoppe Oderich,Gérard Socié,剛徳森田,J. H. Bourhis,Simona Lapusan,Roxane Gay,S. Vigouroux,Jialu Wen,Melody Bolton,A. Huynh,Bruno Lioure,Ibrahim Yakoub‐Agha,Olivier Hermine,Nöel Milpied,Mohamad Mohty,Vitor O. Kuribara	2012	25
4	Activation of cytotoxic T-cell receptor T lymphocytes in response to specific stimulation in myelodysplastic syndromes Haematologica ·Jean‐Jacques Kiladjian,Gian Paolo Visentin,Tian Shu-cheng,Sylvie Chevret,Virginie Éclache,Jérôme Stirnemann,J. H. Bourhis,Salem Chouaı̈b,Pierre Fenaux,Anne Caignard	2008	30
5	High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL) Leukemia ·Elias Jabbour,Serge Koscielny,Catherine Sebban,Mota Velasco Gallardo,Catherine Patte,Thérèse Gargi,Pierre Biron,Christophe Fermé,J. H. Bourhis,J Vantelon,P Arnaud,Vincent Ribrag	2006	25
6	LA CASPOFUNGINE DANS LE TRAITEMENT EMPIRIQUE DES INFECTIONS FONGIQUES Journal de Mycologie Médicale ·J. H. Bourhis	2004	1
7	Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts Leukemia ·Vincent Ribrag,Florence Suzan,Christophe Ravoet,Walter Feremans,A. Guerci,François Dreyfus,Gandhi Damaj,J Vantelon,J. H. Bourhis,Pierre Fenaux	2003	5
8	Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgki n's Lymphomas Leukemia & lymphoma ·Vincent Ribrag,Serge Koscielny,J Vantelon,Christophe Fermé,رأفت سامي حميد,Patrice Carde,J. H. Bourhis,J. N. Munck	2003	11
9	Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study Leukemia & lymphoma ·C. Lhommé,Abbas Naderi,J. H. Bourhis,Patricia Pautier,Nadine Dohollou,Molly Pinckston,Michael Ashman,C. G. Hsu,Valdano Manuel,M. Hayat	2001	12
10	Burkitt's Acute Lymphocytic Leukemia (L3ALL) in Adults Hematology/Oncology Clinics of North America ·Pierre Fenaux,J. H. Bourhis,Vincent Ribrag	2001	8
11	Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies Cancer/Radiothérapie ·T. Girinsky,E Benhamou,J. H. Bourhis,F. Dhermain,Marina I. Bogdan de Maizman,Odalis Maritza,M. Luboinski,Adriana Pérez,J.M. Cosset,Gèrard Socié,D Baume,K. Knothe,E. Briot,Rogerio de jesús Arévalo Mejía,A. Bridier,J. L. Pico	2001	1
12	Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology ·Nathalie Lassau,J. Leclère,A. Aupérin,J. H. Bourhis,Olivier Hartmann,Dominique Valteau‐Couanet,E Benhamou,ERIK V. STÅLBERG,Velasco Suárez,T. Girinski,J L Pico,Rahmah Sharifah	1997	87
13	Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF PubMed ·Élodie Gautier,J. H. Bourhis,C Bayle,Gómez Uriz,J. L. Pico,Gil Tchernia	1997	7
14	Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. Journal of Clinical Oncology ·Gérald Marit,C. Fabères,J L Pico,J.-M. Boiron,J. H. Bourhis,Abbas Naderi,P Bernard,Reza Golpoor,Pascale Cony‐Makhoul,M. Puntous,G Vezon,A Broustet,D Girault,Josy Reiffers	1996	26
15	Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL‐12 pathway Tissue Antigens ·Bernard Bonnotte,Cécile Pardoux,J. H. Bourhis,Anne Caignard,Jean-Luc Overkamp,Jihed Chehimi,Fathia Mami‐Chouaib,Salem Chouaı̈b	1996	8
16	Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value. PubMed ·Judith Landman‐Parker,Gèrard Socié,Thierry Petit,B Raynal,J. H. Bourhis,J L Pico,Olivier Brison	1994	12
17	High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study European Journal of Cancer ·Carlos Becerril-Gutiérrez,Erin L. Jordan,J. H. Bourhis,Nur Annisa Anggraeni,Françoise Beaujean,Patrice Viens,Catherine Lhommé,Zul Aqiman Shukeri,D Maraninchi,Marcel Hayat,Rachel N Todd,Nermina Selimhodžić	1993	23
18	Escalating High-Dose Carboplatin and Autologous Bone Marrow Transplantation in Solid Tumors Oncology ·J. L. Pico,Carlos Becerril-Gutiérrez,Luca Castagna,J. H. Bourhis,Zul Aqiman Shukeri,D Maraninchi,Jean‐Pierre Droz	1993	14
19	Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations. PubMed ·Dieter Dennig,Salaheddine Mécheri,J. H. Bourhis,Michael K. Hoffman	1992	7
20	Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. The Journal of Immunology ·C Keever,Karen Pekle,M. V. Gazzola,N H Collins,J. H. Bourhis,Alfred P. Gillio	1989	14

About J. H. Bourhis

J. H. Bourhis is a scholar working on Hematology, Pathology and Forensic Medicine, Neurology, Oncology and Immunology, having authored 35 papers that have together received 507 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Immune Cell Function and Interaction (5 papers), Cancer therapeutics and mechanisms (4 papers), Neutropenia and Cancer Infections (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers) and Testicular diseases and treatments (3 papers). The work is most often cited by research in Hematology (281 citations), Hepatology (46 citations), Genetics (49 citations), Oncology (117 citations) and Immunology (74 citations). J. H. Bourhis has collaborated with scholars based in France, United States and Italy. Frequent co-authors include J L Pico, Pierre Fenaux, Serge Koscielny, T. Girinski, Christian Denier, Olivier Hartmann, Sylvie Chevret, J. Leclère, Dawn W. Adams and A. Aupérin. Their work appears in journals such as Leukemia, Haematologica, Journal of Clinical Oncology, British Journal of Haematology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact